Abbott Laboratories (ABT) Revenue Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.32% |
| Dec 31, 2025 | 1.38% |
| Sep 30, 2025 | 5.13% |
| Jun 30, 2025 | 8.74% |
| Mar 31, 2025 | 6.04% |
| Dec 31, 2024 | 5.71% |
| Sep 30, 2024 | 5.66% |
| Jun 30, 2024 | 5.40% |
| Mar 31, 2024 | 5.75% |
| Dec 31, 2023 | 5.69% |
| Sep 30, 2023 | 5.79% |
| Jun 30, 2023 | 5.14% |
| Mar 31, 2023 | 5.69% |
| Dec 31, 2022 | 5.86% |
| Sep 30, 2022 | 8.80% |
| Jun 30, 2022 | 11.15% |
| Mar 31, 2022 | 13.43% |
| Dec 31, 2021 | 16.55% |
| Sep 30, 2021 | 15.56% |
| Jun 30, 2021 | 13.90% |
| Mar 31, 2021 | 16.44% |
| Dec 31, 2020 | 15.58% |
| Sep 30, 2020 | 11.44% |
| Jun 30, 2020 | 7.23% |
| Mar 31, 2020 | 9.55% |
| Dec 31, 2019 | 9.19% |
| Sep 30, 2019 | 9.72% |
| Jun 30, 2019 | 9.55% |
| Mar 31, 2019 | 9.64% |
| Dec 31, 2018 | 8.89% |
| Sep 30, 2018 | 9.76% |
| Jun 30, 2018 | 9.50% |
| Mar 31, 2018 | 8.80% |
| Dec 31, 2017 | 6.15% |
| Sep 30, 2017 | 5.34% |
| Jun 30, 2017 | 4.55% |
| Mar 31, 2017 | 3.69% |
| Dec 31, 2016 | -12.47% |
| Sep 30, 2016 | -11.59% |
| Jun 30, 2016 | -11.12% |
| Mar 31, 2016 | -11.58% |
| Dec 31, 2015 | -12.24% |
| Sep 30, 2015 | -9.90% |
| Jun 30, 2015 | -10.14% |
| Mar 31, 2015 | -8.65% |
| Dec 31, 2014 | -9.43% |
| Sep 30, 2014 | -8.13% |
| Jun 30, 2014 | -7.57% |